APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nifedipine API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nifedipine API Industry Growth and Trends Forecast to 2032

29 December 2025107 pages

Choose your research edition.

Industry ResearchNifedipine API Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Nifedipine API Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Nifedipine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nifedipine API Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Nifedipine API Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Nifedipine API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nifedipine API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nifedipine API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nifedipine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nifedipine API include Bayer AG, Cipla Ltd, Delmar Chemicals Inc., Dipharma Francis S.r.l, Moehs Iberica S.L., Sumika Fine Chemicals Co. Ltd., Tecoland Corp, Teva Pharmaceuticals and Siyao Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nifedipine API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nifedipine API market size, estimates, and forecasts are presented in terms of sales volume (K Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nifedipine API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nifedipine API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nifedipine API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nifedipine API Market by Company

Bayer AG

Cipla Ltd

Delmar Chemicals Inc.

Dipharma Francis S.r.l

Moehs Iberica S.L.

Sumika Fine Chemicals Co. Ltd.

Tecoland Corp

Teva Pharmaceuticals

Siyao Pharmaceuticals

Xiyue Pharmaceutical

Zhong'an Pharmaceutical

Yantai Luyin Pharmaceutical

Qingyang Pharmaceutical

Nifedipine API Segment by Type

98% Nifedipine API

99% Nifedipine API

99.9% Nifedipine API

Nifedipine API Segment by Application

Nifedipine Controlled Release Tablets

Nifedipine Extended Release Tablets

Nifedipine API Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nifedipine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nifedipine API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nifedipine API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nifedipine API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nifedipine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 98% Nifedipine API Table 2. Major Company of 99% Nifedipine API Table 3. Major Company of 99.9% Nifedipine API Table 4. Global Nifedipine API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Nifedipine API Sales by Type (2021-2026) & (K Tons) Table 6. Global Nifedipine API Sales Market Share in Volume by Type (2021-2026) Table 7. Global Nifedipine API Sales by Type (2021-2026) & (US$ Million) Table 8. Global Nifedipine API Sales Market Share in Value by Type (2021-2026) Table 9. Global Nifedipine API Price by Type (2021-2026) & (US$/Ton) Table 10. Global Nifedipine API Sales by Type (2027-2032) & (K Tons) Table 11. Global Nifedipine API Sales Market Share in Volume by Type (2027-2032) Table 12. Global Nifedipine API Sales by Type (2027-2032) & (US$ Million) Table 13. Global Nifedipine API Sales Market Share in Value by Type (2027-2032) Table 14. Global Nifedipine API Price by Type (2027-2032) & (US$/Ton) Table 15. North America Nifedipine API Sales by Type (2021-2026) & (K Tons) Table 16. North America Nifedipine API Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Nifedipine API Sales by Type (2021-2026) & (K Tons) Table 18. Europe Nifedipine API Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Nifedipine API Sales by Type (2021-2026) & (K Tons) Table 20. Asia-Pacific Nifedipine API Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Nifedipine API Sales by Type (2021-2026) & (K Tons) Table 22. Latin America Nifedipine API Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Nifedipine API Sales by Type (2021-2026) & (K Tons) Table 24. Middle East and Africa Nifedipine API Sales by Type (2021-2026) & (US$ Million) Table 25. Nifedipine API Industry Trends Table 26. Nifedipine API Industry Drivers Table 27. Nifedipine API Industry Opportunities and Challenges Table 28. Nifedipine API Industry Restraints Table 29. Global Nifedipine API Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Nifedipine API Revenue Market Share by Company (2021-2026) Table 31. Global Nifedipine API Sales by Company (2021-2026) & (K Tons) Table 32. Global Nifedipine API Sales Share by Company (2021-2026) Table 33. Global Nifedipine API Market Price by Company (2021-2026) & (US$/Ton) Table 34. Global Nifedipine API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Nifedipine API Major Company Production Sites and Headquarters Table 36. Global Nifedipine API Company, Product Type & Application Table 37. Global Nifedipine API Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Nifedipine API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Nifedipine API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Nifedipine API Sales by Region (2021-2026) & (K Tons) Table 42. Global Nifedipine API Sales Market Share in Volume by Region (2021-2026) Table 43. Global Nifedipine API Sales by Region (2021-2026) & (US$ Million) Table 44. Global Nifedipine API Sales Market Share in Value by Region (2021-2026) Table 45. Global Nifedipine API Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Global Nifedipine API Sales by Region (2027-2032) & (K Tons) Table 47. Global Nifedipine API Sales Market Share in Volume by Region (2027-2032) Table 48. Global Nifedipine API Sales by Region (2027-2032) & (US$ Million) Table 49. Global Nifedipine API Sales Market Share in Value by Region (2027-2032) Table 50. Global Nifedipine API Sales (K Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 51. Global Nifedipine API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Nifedipine API Sales by Application (2021-2026) & (K Tons) Table 53. Global Nifedipine API Sales Market Share in Volume by Application (2021-2026) Table 54. Global Nifedipine API Sales by Application (2021-2026) & (US$ Million) Table 55. Global Nifedipine API Sales Market Share in Value by Application (2021-2026) Table 56. Global Nifedipine API Price by Application (2021-2026) & (US$/Ton) Table 57. Global Nifedipine API Sales by Application (2027-2032) & (K Tons) Table 58. Global Nifedipine API Sales Market Share in Volume by Application (2027-2032) Table 59. Global Nifedipine API Sales by Application (2027-2032) & (US$ Million) Table 60. Global Nifedipine API Sales Market Share in Value by Application (2027-2032) Table 61. Global Nifedipine API Price by Application (2027-2032) & (US$/Ton) Table 62. North America Nifedipine API Sales by Application (2021-2026) & (K Tons) Table 63. North America Nifedipine API Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Nifedipine API Sales by Application (2021-2026) & (K Tons) Table 65. Europe Nifedipine API Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Nifedipine API Sales by Application (2021-2026) & (K Tons) Table 67. Asia-Pacific Nifedipine API Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Nifedipine API Sales by Application (2021-2026) & (K Tons) Table 69. Latin America Nifedipine API Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Nifedipine API Sales by Application (2021-2026) & (K Tons) Table 71. Middle East and Africa Nifedipine API Sales by Application (2021-2026) & (US$ Million) Table 72. Bayer AG Company Information Table 73. Bayer AG Business Overview Table 74. Bayer AG Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Bayer AG Nifedipine API Product Portfolio Table 76. Bayer AG Recent Development Table 77. Cipla Ltd Company Information Table 78. Cipla Ltd Business Overview Table 79. Cipla Ltd Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Cipla Ltd Nifedipine API Product Portfolio Table 81. Cipla Ltd Recent Development Table 82. Delmar Chemicals Inc. Company Information Table 83. Delmar Chemicals Inc. Business Overview Table 84. Delmar Chemicals Inc. Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Delmar Chemicals Inc. Nifedipine API Product Portfolio Table 86. Delmar Chemicals Inc. Recent Development Table 87. Dipharma Francis S.r.l Company Information Table 88. Dipharma Francis S.r.l Business Overview Table 89. Dipharma Francis S.r.l Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Dipharma Francis S.r.l Nifedipine API Product Portfolio Table 91. Dipharma Francis S.r.l Recent Development Table 92. Moehs Iberica S.L. Company Information Table 93. Moehs Iberica S.L. Business Overview Table 94. Moehs Iberica S.L. Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Moehs Iberica S.L. Nifedipine API Product Portfolio Table 96. Moehs Iberica S.L. Recent Development Table 97. Sumika Fine Chemicals Co. Ltd. Company Information Table 98. Sumika Fine Chemicals Co. Ltd. Business Overview Table 99. Sumika Fine Chemicals Co. Ltd. Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Sumika Fine Chemicals Co. Ltd. Nifedipine API Product Portfolio Table 101. Sumika Fine Chemicals Co. Ltd. Recent Development Table 102. Tecoland Corp Company Information Table 103. Tecoland Corp Business Overview Table 104. Tecoland Corp Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. Tecoland Corp Nifedipine API Product Portfolio Table 106. Tecoland Corp Recent Development Table 107. Teva Pharmaceuticals Company Information Table 108. Teva Pharmaceuticals Business Overview Table 109. Teva Pharmaceuticals Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Teva Pharmaceuticals Nifedipine API Product Portfolio Table 111. Teva Pharmaceuticals Recent Development Table 112. Siyao Pharmaceuticals Company Information Table 113. Siyao Pharmaceuticals Business Overview Table 114. Siyao Pharmaceuticals Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. Siyao Pharmaceuticals Nifedipine API Product Portfolio Table 116. Siyao Pharmaceuticals Recent Development Table 117. Xiyue Pharmaceutical Company Information Table 118. Xiyue Pharmaceutical Business Overview Table 119. Xiyue Pharmaceutical Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 120. Xiyue Pharmaceutical Nifedipine API Product Portfolio Table 121. Xiyue Pharmaceutical Recent Development Table 122. Zhong'an Pharmaceutical Company Information Table 123. Zhong'an Pharmaceutical Business Overview Table 124. Zhong'an Pharmaceutical Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 125. Zhong'an Pharmaceutical Nifedipine API Product Portfolio Table 126. Zhong'an Pharmaceutical Recent Development Table 127. Yantai Luyin Pharmaceutical Company Information Table 128. Yantai Luyin Pharmaceutical Business Overview Table 129. Yantai Luyin Pharmaceutical Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 130. Yantai Luyin Pharmaceutical Nifedipine API Product Portfolio Table 131. Yantai Luyin Pharmaceutical Recent Development Table 132. Qingyang Pharmaceutical Company Information Table 133. Qingyang Pharmaceutical Business Overview Table 134. Qingyang Pharmaceutical Nifedipine API Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 135. Qingyang Pharmaceutical Nifedipine API Product Portfolio Table 136. Qingyang Pharmaceutical Recent Development Table 137. North America Nifedipine API Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 138. North America Nifedipine API Sales by Country (2021-2026) & (K Tons) Table 139. North America Nifedipine API Sales Market Share by Country (2021-2026) Table 140. North America Nifedipine API Sales Forecast by Country (2027-2032) & (K Tons) Table 141. North America Nifedipine API Sales Market Share Forecast by Country (2027-2032) Table 142. North America Nifedipine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Nifedipine API Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Nifedipine API Market Share by Country (2021-2026) Table 145. North America Nifedipine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Nifedipine API Market Share Forecast by Country (2027-2032) Table 147. Europe Nifedipine API Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 148. Europe Nifedipine API Sales by Country (2021-2026) & (K Tons) Table 149. Europe Nifedipine API Sales Market Share by Country (2021-2026) Table 150. Europe Nifedipine API Sales Forecast by Country (2027-2032) & (K Tons) Table 151. Europe Nifedipine API Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Nifedipine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Nifedipine API Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Nifedipine API Market Share by Country (2021-2026) Table 155. Europe Nifedipine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Nifedipine API Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Nifedipine API Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Nifedipine API Sales by Country (2021-2026) & (K Tons) Table 159. Asia-Pacific Nifedipine API Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Nifedipine API Sales Forecast by Country (2027-2032) & (K Tons) Table 161. Asia-Pacific Nifedipine API Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Nifedipine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Nifedipine API Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Nifedipine API Market Share by Country (2021-2026) Table 165. Asia-Pacific Nifedipine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Nifedipine API Market Share Forecast by Country (2027-2032) Table 167. Latin America Nifedipine API Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 168. Latin America Nifedipine API Sales by Country (2021-2026) & (K Tons) Table 169. Latin America Nifedipine API Sales Market Share by Country (2021-2026) Table 170. Latin America Nifedipine API Sales Forecast by Country (2027-2032) & (K Tons) Table 171. Latin America Nifedipine API Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Nifedipine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Nifedipine API Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Nifedipine API Market Share by Country (2021-2026) Table 175. Latin America Nifedipine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Nifedipine API Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Nifedipine API Market Size Growth Rate (CAGR) by Country (K Tons): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Nifedipine API Sales by Country (2021-2026) & (K Tons) Table 179. Middle East and Africa Nifedipine API Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Nifedipine API Sales Forecast by Country (2027-2032) & (K Tons) Table 181. Middle East and Africa Nifedipine API Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Nifedipine API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Nifedipine API Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Nifedipine API Market Share by Country (2021-2026) Table 185. Middle East and Africa Nifedipine API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Nifedipine API Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Nifedipine API Distributors List Table 190. Nifedipine API Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Nifedipine API Image Figure 2. Global Nifedipine API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nifedipine API Market Size (2021-2032) & (US$ Million) Figure 4. Global Nifedipine API Sales (2021-2032) & (K Tons) Figure 5. 98% Nifedipine API Image Figure 6. Global 98% Nifedipine API Sales YoY Growth (2021-2032) & (K Tons) Figure 7. 99% Nifedipine API Image Figure 8. Global 99% Nifedipine API Sales YoY Growth (2021-2032) & (K Tons) Figure 9. 99.9% Nifedipine API Image Figure 10. Global 99.9% Nifedipine API Sales YoY Growth (2021-2032) & (K Tons) Figure 11. Global Nifedipine API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Nifedipine API Market Share by Type 2025 VS 2032 Figure 13. North America Nifedipine API Sales Market Share in Volume by Type in 2025 Figure 14. North America Nifedipine API Sales Market Share in Value by Type in 2025 Figure 15. Europe Nifedipine API Sales Market Share in Volume by Type in 2025 Figure 16. Europe Nifedipine API Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Nifedipine API Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Nifedipine API Sales Market Share in Value by Type in 2025 Figure 19. Latin America Nifedipine API Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Nifedipine API Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Nifedipine API Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Nifedipine API Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Nifedipine API Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Nifedipine Controlled Release Tablets Image Figure 26. Global Nifedipine Controlled Release Tablets Sales YoY Growth (2021-2032) & (K Tons) Figure 27. Nifedipine Extended Release Tablets Image Figure 28. Global Nifedipine Extended Release Tablets Sales YoY Growth (2021-2032) & (K Tons) Figure 29. Global Nifedipine API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Nifedipine API Market Share by Application 2025 VS 2032 Figure 31. North America Nifedipine API Sales Market Share in Volume by Application in 2025 Figure 32. North America Nifedipine API Sales Market Share in Value by Application in 2025 Figure 33. Europe Nifedipine API Sales Market Share in Volume by Application in 2025 Figure 34. Europe Nifedipine API Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Nifedipine API Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Nifedipine API Sales Market Share in Value by Application in 2025 Figure 37. Latin America Nifedipine API Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Nifedipine API Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Nifedipine API Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Nifedipine API Sales Market Share in Value by Application in 2025 Figure 41. North America Nifedipine API Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 42. North America Nifedipine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Nifedipine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Nifedipine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Nifedipine API Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 46. Europe Nifedipine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Nifedipine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Nifedipine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Nifedipine API Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 50. Asia-Pacific Nifedipine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Nifedipine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Nifedipine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Nifedipine API Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 54. Latin America Nifedipine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Nifedipine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Nifedipine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Nifedipine API Sales by Country: 2021 VS 2025 VS 2032 (K Tons) Figure 58. Middle East and Africa Nifedipine API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Nifedipine API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Nifedipine API Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Nifedipine API Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Nifedipine API Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 98% Nifedipine API
  • 99% Nifedipine API
  • 99.9% Nifedipine API
Applications
  • Nifedipine Controlled Release Tablets
  • Nifedipine Extended Release Tablets
Companies covered
  • Bayer AG
  • Cipla Ltd
  • Delmar Chemicals Inc.
  • Dipharma Francis S.r.l
  • Moehs Iberica S.L.
  • Sumika Fine Chemicals Co. Ltd.
  • Tecoland Corp
  • Teva Pharmaceuticals
  • Siyao Pharmaceuticals
  • Xiyue Pharmaceutical
  • Zhong'an Pharmaceutical
  • Yantai Luyin Pharmaceutical
  • Qingyang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nifedipine API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nifedipine API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nifedipine API Market by Type
  6. 1.3.1 98% Nifedipine API
  7. 1.3.2 99% Nifedipine API
  8. 1.3.3 99.9% Nifedipine API
  9. 1.4 Global Nifedipine API Market Size by Type
  10. 1.4.1 Global Nifedipine API Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Nifedipine API Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Nifedipine API Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Nifedipine API Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Nifedipine API Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Nifedipine API Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Nifedipine API Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Nifedipine API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nifedipine API Industry Trends
  2. 2.2 Nifedipine API Industry Drivers
  3. 2.3 Nifedipine API Industry Opportunities and Challenges
  4. 2.4 Nifedipine API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nifedipine API Revenue (2021-2026)
  2. 3.2 Global Top Players by Nifedipine API Sales (2021-2026)
  3. 3.3 Global Top Players by Nifedipine API Price (2021-2026)
  4. 3.4 Global Nifedipine API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nifedipine API Major Company Production Sites & Headquarters
  6. 3.6 Global Nifedipine API Company, Product Type & Application
  7. 3.7 Global Nifedipine API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nifedipine API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nifedipine API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nifedipine API Tier 1, Tier 2, and Tier 3
4 Nifedipine API Regional Status and Outlook
  1. 4.1 Global Nifedipine API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nifedipine API Historic Market Size by Region
  3. 4.2.1 Global Nifedipine API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nifedipine API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nifedipine API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nifedipine API Forecasted Market Size by Region
  7. 4.3.1 Global Nifedipine API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nifedipine API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nifedipine API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nifedipine API by Application
  1. 5.1 Nifedipine API Market by Application
  2. 5.1.1 Nifedipine Controlled Release Tablets
  3. 5.1.2 Nifedipine Extended Release Tablets
  4. 5.2 Global Nifedipine API Market Size by Application
  5. 5.2.1 Global Nifedipine API Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Nifedipine API Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Nifedipine API Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Nifedipine API Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Nifedipine API Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Nifedipine API Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Nifedipine API Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Nifedipine API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Bayer AG
  2. 6.1.1 Bayer AG Company Information
  3. 6.1.2 Bayer AG Business Overview
  4. 6.1.3 Bayer AG Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Bayer AG Nifedipine API Product Portfolio
  6. 6.1.5 Bayer AG Recent Developments
  7. 6.2 Cipla Ltd
  8. 6.2.1 Cipla Ltd Company Information
  9. 6.2.2 Cipla Ltd Business Overview
  10. 6.2.3 Cipla Ltd Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cipla Ltd Nifedipine API Product Portfolio
  12. 6.2.5 Cipla Ltd Recent Developments
  13. 6.3 Delmar Chemicals Inc.
  14. 6.3.1 Delmar Chemicals Inc. Company Information
  15. 6.3.2 Delmar Chemicals Inc. Business Overview
  16. 6.3.3 Delmar Chemicals Inc. Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Delmar Chemicals Inc. Nifedipine API Product Portfolio
  18. 6.3.5 Delmar Chemicals Inc. Recent Developments
  19. 6.4 Dipharma Francis S.r.l
  20. 6.4.1 Dipharma Francis S.r.l Company Information
  21. 6.4.2 Dipharma Francis S.r.l Business Overview
  22. 6.4.3 Dipharma Francis S.r.l Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Dipharma Francis S.r.l Nifedipine API Product Portfolio
  24. 6.4.5 Dipharma Francis S.r.l Recent Developments
  25. 6.5 Moehs Iberica S.L.
  26. 6.5.1 Moehs Iberica S.L. Company Information
  27. 6.5.2 Moehs Iberica S.L. Business Overview
  28. 6.5.3 Moehs Iberica S.L. Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Moehs Iberica S.L. Nifedipine API Product Portfolio
  30. 6.5.5 Moehs Iberica S.L. Recent Developments
  31. 6.6 Sumika Fine Chemicals Co. Ltd.
  32. 6.6.1 Sumika Fine Chemicals Co. Ltd. Company Information
  33. 6.6.2 Sumika Fine Chemicals Co. Ltd. Business Overview
  34. 6.6.3 Sumika Fine Chemicals Co. Ltd. Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Sumika Fine Chemicals Co. Ltd. Nifedipine API Product Portfolio
  36. 6.6.5 Sumika Fine Chemicals Co. Ltd. Recent Developments
  37. 6.7 Tecoland Corp
  38. 6.7.1 Tecoland Corp Company Information
  39. 6.7.2 Tecoland Corp Business Overview
  40. 6.7.3 Tecoland Corp Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Tecoland Corp Nifedipine API Product Portfolio
  42. 6.7.5 Tecoland Corp Recent Developments
  43. 6.8 Teva Pharmaceuticals
  44. 6.8.1 Teva Pharmaceuticals Company Information
  45. 6.8.2 Teva Pharmaceuticals Business Overview
  46. 6.8.3 Teva Pharmaceuticals Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Teva Pharmaceuticals Nifedipine API Product Portfolio
  48. 6.8.5 Teva Pharmaceuticals Recent Developments
  49. 6.9 Siyao Pharmaceuticals
  50. 6.9.1 Siyao Pharmaceuticals Company Information
  51. 6.9.2 Siyao Pharmaceuticals Business Overview
  52. 6.9.3 Siyao Pharmaceuticals Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Siyao Pharmaceuticals Nifedipine API Product Portfolio
  54. 6.9.5 Siyao Pharmaceuticals Recent Developments
  55. 6.10 Xiyue Pharmaceutical
  56. 6.10.1 Xiyue Pharmaceutical Company Information
  57. 6.10.2 Xiyue Pharmaceutical Business Overview
  58. 6.10.3 Xiyue Pharmaceutical Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Xiyue Pharmaceutical Nifedipine API Product Portfolio
  60. 6.10.5 Xiyue Pharmaceutical Recent Developments
  61. 6.11 Zhong'an Pharmaceutical
  62. 6.11.1 Zhong'an Pharmaceutical Company Information
  63. 6.11.2 Zhong'an Pharmaceutical Business Overview
  64. 6.11.3 Zhong'an Pharmaceutical Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Zhong'an Pharmaceutical Nifedipine API Product Portfolio
  66. 6.11.5 Zhong'an Pharmaceutical Recent Developments
  67. 6.12 Yantai Luyin Pharmaceutical
  68. 6.12.1 Yantai Luyin Pharmaceutical Company Information
  69. 6.12.2 Yantai Luyin Pharmaceutical Business Overview
  70. 6.12.3 Yantai Luyin Pharmaceutical Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Yantai Luyin Pharmaceutical Nifedipine API Product Portfolio
  72. 6.12.5 Yantai Luyin Pharmaceutical Recent Developments
  73. 6.13 Qingyang Pharmaceutical
  74. 6.13.1 Qingyang Pharmaceutical Company Information
  75. 6.13.2 Qingyang Pharmaceutical Business Overview
  76. 6.13.3 Qingyang Pharmaceutical Nifedipine API Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Qingyang Pharmaceutical Nifedipine API Product Portfolio
  78. 6.13.5 Qingyang Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Nifedipine API Sales by Country
  2. 7.1.1 North America Nifedipine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nifedipine API Sales by Country (2021-2026)
  4. 7.1.3 North America Nifedipine API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nifedipine API Market Size by Country
  6. 7.2.1 North America Nifedipine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nifedipine API Market Size by Country (2021-2026)
  8. 7.2.3 North America Nifedipine API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nifedipine API Sales by Country
  2. 8.1.1 Europe Nifedipine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nifedipine API Sales by Country (2021-2026)
  4. 8.1.3 Europe Nifedipine API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nifedipine API Market Size by Country
  6. 8.2.1 Europe Nifedipine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nifedipine API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nifedipine API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nifedipine API Sales by Country
  2. 9.1.1 Asia-Pacific Nifedipine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nifedipine API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nifedipine API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nifedipine API Market Size by Country
  6. 9.2.1 Asia-Pacific Nifedipine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nifedipine API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nifedipine API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nifedipine API Sales by Country
  2. 10.1.1 South America Nifedipine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nifedipine API Sales by Country (2021-2026)
  4. 10.1.3 South America Nifedipine API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nifedipine API Market Size by Country
  6. 10.2.1 South America Nifedipine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nifedipine API Market Size by Country (2021-2026)
  8. 10.2.3 South America Nifedipine API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nifedipine API Sales by Country
  2. 11.1.1 Middle East and Africa Nifedipine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nifedipine API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nifedipine API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nifedipine API Market Size by Country
  6. 11.2.1 Middle East and Africa Nifedipine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nifedipine API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nifedipine API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nifedipine API Value Chain Analysis
  2. 12.1.1 Nifedipine API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nifedipine API Production Mode & Process
  7. 12.2 Nifedipine API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nifedipine API Distributors
  10. 12.2.3 Nifedipine API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst